General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Eidos Therapeutics (MODEST), Cytokenetics(MODEST), Alnylam(MODEST) SPEAKER'S BUREAU: Bristol-Myers Squibb Company (MODEST), Alnylam(SIGNIFICANT)

View Full Disclosure